Kuznicki Law PLLC notifies investors that a class action has commenced in the United States District Court for the Southern District of Texas on behalf of shareholders of Nutex Health Inc. who purchased shares between August 8, 2024 and August 14, 2025.
Nutex and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 14, 2025, post-market, the Company disclosed that it would “delay filing its Form 10-Q for the period ending June 30, 2025” due to “non-cash accounting adjustments related to the treatment of stock-based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings.”
On this news, the price of Nutex’s shares fell $18.22 per share, or 16.39%, to close at $92.91 per share on August 15, 2025.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until October 21, 2025 to request that the court appoint them lead plaintiff.